Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PHR

PHR - Phreesia Inc Stock Price, Fair Value and News

$14.67-0.52 (-3.42%)
Market Closed

43/100

PHR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

43/100

PHR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$13.86

Target 3M

$15.32

Target 6M

$14.81

PHR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PHR Price Action

Last 7 days

-6.1%

Last 30 days

-13.7%

Last 90 days

-35.3%

Trailing 12 Months

-49.9%

PHR RSI Chart

PHR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PHR Valuation

Market Cap

884.4M

Price/Earnings (Trailing)

-164.42

Price/Sales (Trailing)

1.91

EV/EBITDA

29.8

Price/Free Cashflow

17.66

PHR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$13.86

Target 3M

$15.32

Target 6M

$14.81

PHR Fundamentals

PHR Revenue

Revenue (TTM)

463.2M

Rev. Growth (Yr)

12.67%

Rev. Growth (Qtr)

2.63%

PHR Earnings

Earnings (TTM)

-5.4M

Earnings Growth (Yr)

129.65%

Earnings Growth (Qtr)

553.06%

PHR Profitability

EBT Margin

-0.86%

Return on Equity

-1.68%

Return on Assets

-1.27%

Free Cashflow Yield

5.66%

PHR Investor Care

Shares Dilution (1Y)

3.72%

Diluted EPS (TTM)

-0.1

PHR Alerts

  • 5 major insider sales recently.
  • Big jump in Earnings (Y/Y)

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025419.8M434.5M449.7M463.2M
2024356.3M373.7M390.0M405.1M
2023280.9M301.4M319.4M337.9M
2022213.2M228.3M245.2M262.3M
2021148.7M163.6M179.6M197.0M
2020124.8M129.9M134.1M139.7M
201999.9M104.3M110.4M118.5M
201879.8M84.8M89.9M94.9M
Get all data in R, Python etc through our Historical Stock Data APIs

About Phreesia Inc

PHR
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Wilmington, Delaware.
 CEO
 WEBSITEphreesia.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES1576

Phreesia Inc Frequently Asked Questions

PHR is the stock ticker symbol of Phreesia Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Phreesia Inc is 884.41 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PHR's fair value in chart for subscribers.

The fair value guage provides a quick view whether PHR is over valued or under valued. Whether Phreesia Inc is cheap or expensive depends on the assumptions which impact Phreesia Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PHR.

As of Wed Jan 28 2026, PHR's PE ratio (Price to Earnings) is -164.42 and Price to Sales (PS) ratio is 1.91. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PHR PE ratio will change depending on the future growth rate expectations of investors.